iOmx Therapeutics
Healthcare
HQ: Martinsried, Germany
Investors: 1
Identifies novel immune-checkpoint targets for cancer immunotherapy
Investors (1)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Sofinnova Partners | Current | - | - | Website |
Get these signals delivered weekly
Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.
Get Signals